Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cresco Labs (CRLBF) Other Operating Expenses (2020 - 2025)

Historic Other Operating Expenses for Cresco Labs (CRLBF) over the last 6 years, with Q3 2025 value amounting to $1.4 million.

  • Cresco Labs' Other Operating Expenses rose 2810000.0% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.4 million, marking a year-over-year increase of 9592.03%. This contributed to the annual value of -$61.9 million for FY2024, which is 365913.79% down from last year.
  • Latest data reveals that Cresco Labs reported Other Operating Expenses of $1.4 million as of Q3 2025, which was up 2810000.0% from -$836000.0 recorded in Q2 2025.
  • In the past 5 years, Cresco Labs' Other Operating Expenses registered a high of $13.3 million during Q4 2022, and its lowest value of -$59.5 million during Q2 2024.
  • Moreover, its 5-year median value for Other Operating Expenses was $183500.0 (2023), whereas its average is -$2.7 million.
  • Its Other Operating Expenses has fluctuated over the past 5 years, first crashed by 1490298.51% in 2024, then skyrocketed by 2810000.0% in 2025.
  • Over the past 5 years, Cresco Labs' Other Operating Expenses (Quarter) stood at $10.9 million in 2021, then rose by 21.65% to $13.3 million in 2022, then tumbled by 99.62% to $50000.0 in 2023, then plummeted by 6644.0% to -$3.3 million in 2024, then surged by 142.79% to $1.4 million in 2025.
  • Its last three reported values are $1.4 million in Q3 2025, -$836000.0 for Q2 2025, and $317000.0 during Q1 2025.